Literature DB >> 12026217

Study of the complexation behavior of tenoxicam with cyclodextrins in solution: improved solubility and percutaneous permeability.

Edurne Larrucea1, Adriana Arellano, Susana Santoyo, Pilar Ygartua.   

Abstract

Complexation of tenoxicam (TEN) with gamma-, HPgamma-, beta,-, HPbeta-, and Mbeta-cyclodextrin (CD) in aqueous solution at pH 7.4 has been investigated using phase solubility diagrams. TEN formed soluble complexes with 1:1 stoichiometry with all the CDs studied, although the inclusion stability constants (K1:1) obtained had low values. The presence of propylene glycol (PG) in the dissolution medium decreased the stability constants and led to a higher fraction of free drug by competitive displacement and by an increase in the lipophility of the media. Among the CDs tested, MbetaCD was chosen for further studies since TEN-MbetaCD complexes yielded the best results: good solubility and the highest stability constant. The effect of MbetaCD and PG on the TENpartitioning coefficient was also studied in skin-buffer systems. Although each substance reduced the partitioning value, the combination of PG and MbetaCD increased this parameter. The noticeable increase in solubility of the drug found in the presence of MbetaCD allowed the formulation of carbopol gels with higher doses of TEN and a reduced amount of cosolvent. The presence of MbetaCD improved the percutaneous penetration of TEN through abdominal rat skin by increasing the solubility of the drug in the vehicle and by affecting the partitioning behavior of TEN in the skin. In addition, TEN retention in the skin was found to be related to the flux values attained with the corresponding gels.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12026217     DOI: 10.1081/ddc-120002840

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  1 in total

1.  Cyclodextrins in delivery systems: Applications.

Authors:  Gaurav Tiwari; Ruchi Tiwari; Awani K Rai
Journal:  J Pharm Bioallied Sci       Date:  2010-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.